RIL
TNXP icon

Rothschild Investment LLC’s Tonix Pharmaceuticals TNXP Stock Holding History

Rothschild Investment LLC’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18K Buy
86
+85
+8,500% +$1.31K ﹤0.01% 2798
2025
Q4 		$16 Buy
+1
New +$18 ﹤0.01% 3353

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rothschild Investment LLC's TNXP Position: Q1 2026 in Review

Rothschild Investment LLC increased its Tonix Pharmaceuticals (TNXP) stake by 8,500% in Q1 2026, buying an estimated $1.31K and bringing the position to 86 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.

Rothschild Investment LLC first reported a position in TNXP in Q4 2025 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Rothschild Investment LLC held 86 shares of Tonix Pharmaceuticals worth $1.18K as of Q1 2026.
  • Rothschild Investment LLC bought 85 Tonix Pharmaceuticals shares in Q1 2026, an estimated $1.31K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2798 holding.
  • Rothschild Investment LLC first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.